Neurotoxicity of cancer chemotherapy

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Neurologic dysfunction is a common side effect of many chemotherapy drugs. For several agents, neurotoxicity is common, severe, and can be dose-limiting. As the list of newer chemotherapy agents and systemic targeted therapies grows, so does the number and variety of potential neurotoxicities. This is a review of the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.

Original languageEnglish
Pages (from-to)273-286
Number of pages14
JournalSeminars in Neurology
Volume30
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Drug Therapy
Neoplasms
Peripheral Nervous System
Neurologic Manifestations
Central Nervous System
Pharmaceutical Preparations
Therapeutics

Keywords

  • Chemotherapy adverse effects
  • polyneuropathy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Neurotoxicity of cancer chemotherapy. / Dropcho, Edward.

In: Seminars in Neurology, Vol. 30, No. 3, 2010, p. 273-286.

Research output: Contribution to journalArticle

@article{9c3fde10eb2c4376af24622528f523e8,
title = "Neurotoxicity of cancer chemotherapy",
abstract = "Neurologic dysfunction is a common side effect of many chemotherapy drugs. For several agents, neurotoxicity is common, severe, and can be dose-limiting. As the list of newer chemotherapy agents and systemic targeted therapies grows, so does the number and variety of potential neurotoxicities. This is a review of the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.",
keywords = "Chemotherapy adverse effects, polyneuropathy",
author = "Edward Dropcho",
year = "2010",
doi = "10.1055/s-0030-1255217",
language = "English",
volume = "30",
pages = "273--286",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Neurotoxicity of cancer chemotherapy

AU - Dropcho, Edward

PY - 2010

Y1 - 2010

N2 - Neurologic dysfunction is a common side effect of many chemotherapy drugs. For several agents, neurotoxicity is common, severe, and can be dose-limiting. As the list of newer chemotherapy agents and systemic targeted therapies grows, so does the number and variety of potential neurotoxicities. This is a review of the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.

AB - Neurologic dysfunction is a common side effect of many chemotherapy drugs. For several agents, neurotoxicity is common, severe, and can be dose-limiting. As the list of newer chemotherapy agents and systemic targeted therapies grows, so does the number and variety of potential neurotoxicities. This is a review of the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.

KW - Chemotherapy adverse effects

KW - polyneuropathy

UR - http://www.scopus.com/inward/record.url?scp=77954150370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954150370&partnerID=8YFLogxK

U2 - 10.1055/s-0030-1255217

DO - 10.1055/s-0030-1255217

M3 - Article

VL - 30

SP - 273

EP - 286

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 3

ER -